Accresa Secures Second U.S. Patent, Asserts Leadership and Ownership of DPC Technology

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The only known patented technology platform in direct primary care reinforces its intellectual property rights in healthcare affiliate management and payment technology.

Accresa Health, a pioneer in direct primary care (DPC) technology, today announced the issuance of its second U.S. patent (No. 12,770,120 B2), further establishing its position as the only known DPC technology platform holding issued U.S. patents.

The new patent strengthens Accresa's intellectual property portfolio covering innovations in affiliate management, healthcare network administration, and payment technology. Together with its first U.S. patent (No. 12,682,329 B2), it protects inventions developed by Accresa to manage complex relationships and financial transactions among employers, healthcare providers, medical groups, and patients.

"Accresa developed this technology through years of investment, innovation, and hard work. The issuance of our second U.S. patent further affirms our ownership of the intellectual property underlying these innovations," said William C. Short, CEO of Accresa. "Others have attempted to replicate to compete, but innovation and imitation are not the same thing. We intend to aggressively protect our intellectual property and pursue every appropriate avenue to enforce our patent rights, including against companies currently commercializing technology that infringes our patents. We will not stand by while others profit from innovations we worked to create."

Accresa remains committed to advancing the growth and accessibility of direct primary care, a model the company believes is essential to building a better healthcare system in America. By continuing to invest in innovative technology that simplifies administration, connects healthcare networks, and streamlines payments, Accresa aims to help more employers, providers, and patients benefit from the affordability, accessibility, and personalized care that DPC makes possible.

About Accresa

Accresa is a healthcare technology company specializing in payment and administration solutions for direct primary care and other subscription-based healthcare models. Its patented technology supports healthcare affiliate management, network administration, and integrated payment infrastructure. Learn more at www.accresa.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.54
-4.33 (-1.60%)
AAPL  355.06
+6.55 (1.88%)
AMD  564.53
+49.32 (9.57%)
BAC  50.79
+0.11 (0.22%)
GOOG  292.79
+7.87 (2.76%)
META  639.63
-1.76 (-0.27%)
MSFT  521.88
-11.27 (-2.11%)
NVDA  177.12
+8.23 (4.87%)
ORCL  129.99
+12.01 (10.18%)
TSLA  393.45
+13.67 (3.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.